Recurrent HER2-Positive Breast Carcinoma

specific

The reemergence of HER2-positive breast carcinoma after a period of remission.

Centers

Active Trials

—

Cancer Funding

Top Centers for Recurrent HER2-Positive Breast Carcinoma(47)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive	—	—	51.1
2	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive	—	—	51.1
3	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive	—	—	51.1
4	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive	—	—	51.1
5	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive	—	—	51.1
6	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive	—	—	51.1
7	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive	—	—	51.1
8	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive	—	—	51.1
9	Masonic Cancer CenterMinneapolis, MN NCI Comprehensive	—	—	51.1
10	University of Wisconsin Carbone Cancer CenterMadison, WI NCI Comprehensive	—	—	51.1
11	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive	—	—	51.1
12	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	—	51.1
13	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive	—	—	51.1
14	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive	—	—	51.1
15	Montefiore Einstein Comprehensive Cancer CenterBronx, NY NCI Comprehensive	—	—	51.1
16	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive	—	—	51.1
17	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	—	51.1
18	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical	—	—	51.1
19	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive	—	—	51.1
20	VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive	—	—	51.1
21	UMass Memorial Health Cancer CenterWorcester, MA	—	—	51.1
22	Cleveland Clinic Cancer CenterCleveland, OH	—	—	51.1
23	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive	—	—	51.1
24	Atrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-Salem, NC NCI Comprehensive	—	—	51.1
25	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical	—	—	51.1
26	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive	—	—	51.1
27	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive	—	—	51.1
28	University of Illinois Cancer CenterChicago, IL	—	—	51.1
29	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical	—	—	51.1
30	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive	—	—	51.1
31	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR	—	—	51.1
32	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive	—	—	51.1
33	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX	—	—	51.1
34	Cancer Center at IllinoisUrbana, IL	—	—	51.1
35	Stony Brook Cancer CenterStony Brook, NY	—	—	51.1
36	Penn State Cancer InstituteHershey, PA	—	—	51.1
37	University of Cincinnati Cancer CenterCincinnati, OH	—	—	51.1
38	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL	—	—	51.1
39	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ	—	—	51.1
40	Georgia Cancer Center, Augusta UniversityAugusta, GA	—	—	51.1
41	Ellis Fischel Cancer Center, MU Health CareColumbia, MO	—	—	51.1
42	Upstate Cancer CenterSyracuse, NY	—	—	51.1
43	University of Texas Medical Branch Cancer CenterGalveston, TX	—	—	51.1
44	Loma Linda University Cancer CenterLoma Linda, CA	—	—	51.1
45	BC CancerVancouver, BC	—	—	51.1
46	Louisiana Cancer Research CenterNew Orleans, LA	—	—	51.1
47	Princess Margaret Cancer CentreToronto, ON	—	—	51.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →